Ultimately, we have elucidated the secretion mechanism of HGF in CAFs mediated by the HA–HRH2 signaling pathway, as well as the signaling pathways and molecular mechanisms through which HGF promotes the progression of CCA with a series of in vitro/vivo experiments and a clinical cohort. Here, HGF is linked to cholangiocarcinoma.